Related Experiment Video

Updated: Aug 23, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K

Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

Setsuko K Chambers1

  • 1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.

Cancers
|October 27, 2022
PubMed

Insights

Endometrial cancer is understood as multiple diseases. Molecular insights are driving targeted therapies and improving patient treatment options.

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Translational Medicine

Background:

  • Endometrial cancer is increasingly recognized as a heterogeneous disease.
  • Distinct molecular subtypes necessitate tailored treatment strategies.
  • Advances in molecular characterization are crucial for understanding disease behavior.

Purpose of the Study:

  • To provide an overview of recent advances in endometrial cancer treatment.
  • To highlight the impact of molecular subtyping on therapeutic development.
  • To discuss the application of targeted therapies in endometrial cancer.

Main Methods:

  • Review of current literature on endometrial cancer molecular subtypes.
  • Analysis of targeted therapy development based on molecular profiling.
  • Cross-comparison with molecularly similar cancers.

Main Results:

  • Identification of distinct molecularly defined endometrial cancer cohorts.
  • Development and testing of targeted therapies for specific subtypes.
  • Emerging treatment strategies informed by molecular insights.

Conclusions:

  • Personalized medicine approaches are transforming endometrial cancer care.
  • Molecular characterization is key to optimizing treatment efficacy.
  • Continued research into targeted therapies promises improved patient outcomes.
Keywords:
endometrial cancermolecular subtypingtargeted therapy

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K